FDA Adverse Event
Malfunction
Summary report: N
THERASCREEN® FGFR RGQ RT-PCR KIT
MDR report key: 15348243
·
Received September 2, 2022
Report
- Report Number
- 3004013603-2022-00004
- Event Type
- Malfunction
- Date Received
- September 2, 2022
- Date of Event
- March 9, 2022
- Report Date
- September 2, 2022
- Manufacturer
- QIAGEN GMBH
- Product Code
- OWD
- Removal / Correction Number
- Z-1650-2022
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
A PATIENT SUBJECT HAD BEEN ENROLLED INTO A CLINICAL STUDY FOR ERDAFITINIB BASED ON A FALSE POSITIVE RESULT OBTAINED WITH REF 1108661 THERASCREEN FGFR RGQ RT- PCR KIT (IUO) AND EXPERIENCED SIDE EFFECTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1340421 | THERASCREEN® FGFR RGQ RT-PCR KIT | SOMATIC GENE MUTATION DETECTION SYSTEM | OWD | QIAGEN GMBH | 169047272 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Other |